Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study

The Lancet Diabetes and Endocrinology

Volumn 6, Issue 6, 2018, Pages 455-463

  Herrington, William G ^a   Alegre Díaz, Jesus ^b   Wade, Rachel ^a   Gnatiuc, Louisa ^a   Ramirez Reyes, Raúl ^b   Hill, Michael ^a   Solano Sánchez, Martha ^b   Baigent, Colin ^a   Lewington, Sarah ^a   Collins, Rory ^a   Tapia Conyer, Roberto ^b   Peto, Richard ^a   Kuri Morales, Pablo ^b   Emberson, Jonathan R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MEXICO; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; TIME FACTOR;

ADULT; AGED; BLOOD GLUCOSE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 85044169821     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(18)30050-0     Document Type: Article

References (26)

1. International Diabetes Federation. IDF Diabetes Atlas. 8th edn., 2017, International Diabetes Federation, Brussels http://www.diabetesatlas.org/resources/2017-atlas.html (accessed Dec 29, 2017).
2. Rao Kondapally Seshasai, S, Kaptoge, S, Thompson, A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364 (2011), 829–841.
3. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010), 2215–2222.
4. Zoungas, S, Woodward, M, Li, Q, et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia 57 (2014), 2465–2474.
5. Wannamethee, SG, Shaper, AG, Whincup, PH, Lennon, L, Sattar, N, Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 171 (2011), 404–410.
6. Fox, CS, Sullivan, L, D'Agostino, RB Sr, Wilson, PW, The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 27 (2004), 704–708.
7. Flores-Hernández, S, Saturno-Hernández, PJ, Reyes-Morales, H, Barrientos-Gutiérrez, T, Villalpando, S, Hernández-Ávila, M, Quality of diabetes care: the challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012). PLoS One, 10, 2015, e0133958.
8. Alegre-Díaz, J, Herrington, W, López-Cervantes, M, et al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med 375 (2016), 1961–1971.
9. Tapia-Conyer, R, Kuri-Morales, P, Alegre-Díaz, J, et al. Cohort profile: the Mexico City Prospective Study. Int J Epidemiol 35 (2006), 243–249.
10. Youngman, LD, Clark, S, Manley, S, Peto, R, Collins, R, Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies. Clin Chem 48 (2002), 1627–1629.
11. 1c . NGSP. http://www.ngsp.org/docs/IFCCstd.pdf (accessed Feb 27, 2018).
12. International statistical classification of diseases and related health problems: 10th revision (ICD-10). Vol 2, 2004, World Health Organization, Geneva.
13. Plummer, M, Improved estimates of floating absolute risk. Stat Med 23 (2004), 93–104.
14. Lewis, EJ, Hunsicker, LG, Clarke, WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345 (2001), 851–860.
15. Bragg, F, Holmes, MV, Iona, A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA 317 (2017), 280–289.
16. Peters, SA, Huxley, RR, Woodward, M, Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet 383 (2014), 1973–1980.
17. Natarajan, S, Liao, Y, Sinha, D, Cao, G, McGee, DL, Lipsitz, SR, Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 165 (2005), 430–435.
18. Salles, GF, Bloch, KV, Cardoso, CR, Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients. Diabetes Care 27 (2004), 1299–1305.
19. Turnbull, FM, Abraira, C, Anderson, RJ, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52 (2009), 2288–2298.
20. Zoungas, S, Arima, H, Gerstein, HC, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol 5 (2017), 431–437.
21. Di Angelantonio, E, Gao, P, Khan, H, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 311 (2014), 1225–1233.
22. WHO. Global report on diabetes. 2016, World Health Organization, Geneva apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf (accessed Sept 25, 2017).
23. México Gobierno de la República. Estrategia nacional para la prevención y el control del sobrepeso, la obesidad y la diabetes. 2013, Secretaría de Salud, Mexico City https://www.gob.mx/cms/uploads/attachment/file/200355/Estrategia_nacional_para_prevencion_y_control_de_sobrepeso_obesidad_y_diabetes.pdf (accessed March 5, 2018).
24. Guthrie, A, Fleck, F, Quality of care is key to tackling Mexico's diabetes emergency. Bull World Health Organ 95 (2017), 393–394.
25. Barquera, S, Campos-Nonato, I, Aguilar-Salinas, C, Lopez-Ridaura, R, Arredondo, A, Rivera-Dommarco, J, Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy. Global Health, 9, 2013, 3.
26. Bonilla-Chacín, ME, Aguilera, N, The Mexican social protection system in health. 2013, World Bank, Washington, DC http://siteresources.worldbank.org/HEALTHNUTRITIONANDPOPULATION/Images/MexicanSocialProtectionSysteminHealth.pdf (accessed Feb 27, 2018).